برنامه ملی ثبت ام اس

English

کنگره‌ها (ام اس):

“2025”

  1. Addressing Over fitting in Imbalanced Dataset for MS Progression Prediction/ ICICT 2025, London, UK

“2024”

  1. Urological Symptoms in Iranian Patients with Multiple Sclerosis: Prevalence, Characteristics, and Associations with DMDs for optimum Management / ECTRIMS 2024 – 40th Congress of ECTRIMS / Copenhagen, Denmark
  2. AI-Driven Stratification of Multiple Sclerosis Subtypes: A Study on Clinical Feature-Based Classification in Iranian Patients / ECTRIMS 2024 – 40th Congress of ECTRIMS  / Copenhagen, Denmark
  3. Patterns and Determinants of Disease-Modifying Drug Changes in Multiple Sclerosis Patients in Tehran: An Analysis of the Nationwide MS Registry of Iran / ECTRIMS 2024 – 40th Congress of ECTRIMS  / Copenhagen, Denmark
  4. Uncovering Environmental Risk Factors of Late-Onset Multiple Sclerosis: A Population-Based Case-Control Study from Iran / ECTRIMS 2024 – 40th Congress of ECTRIMS  / Copenhagen, Denmark

“2023”

  1. Uncovering Trends and Patterns in Disease Modifying Drug Use and Change: A Cross-Sectional Study from the Tehran MS Registry, Iran / ECTRIMS 2023
  2. Evaluating the Influential Factors on the Time Interval between the Symptoms Onset and Diagnosis of Patients with Multiple Sclerosis / ECTRIMS 2023
  3. Parental Consanguinity and the Age at Onset in Multiple Sclerosis: A National Registry-Based Analysis of Familial Cases of Iran / MENACTRIMS 2023
  4. Revolutionizing MS Care and Research: Inside Iran’s Nationwide Multiple Sclerosis Registry / MENACTRIMS 2023
  5. Prevalence and Clinical Characteristics of Urological Symptoms in Iranian Multiple Sclerosis Patients: Implications for Quality of Life and Management / MENACTRIMS 2023

“2022”

  1. Epidemiology of Multiple Sclerosis in Iran in 2021 / ECTRIMS 2022
  2. The Association Between Reproductive Characteristics and Disability in Iranian Female Patients with Multiple Sclerosis a Nationwide Registry-based Cross-sectional Study / ECTRIMS 2022
  3. The Rate and Pattern of Changes in MS Disease Modifying Drugs in Tehran, Iran; a Cross-Sectional Study from Tehran MS Registry / MENACTRIMS 2022
  4. Is there a Link Between Multiple Sclerosis and Pregnancy in Terms of Tendency, Reproductive Characteristics, and Disability? A Secondary Data Analysis of Nationwide MS Registry of Iran / MENACTRIMS 2022
  5. Rate of Parental Consanguineous Marriage Among Familial Multiple Sclerosis Patients in Iran: A National Registry-Based Study / MENACTRIMS 2022
  6. Predicting COVID-19 Infection in MS patients using discriminant analysis model / MENACTRIMS 2022
  7. Epidemiological parameters of multiple sclerosis in Chaharmahal- Bakhtiari province, Iran / MENACTRIMS 2022
  8. اپیدمیولوژی ام‌اس در ایران (آنچه از رجیستری ام‌اس می‌دانیم) / بیست و نهمین کنگره بین‌المللی نورولوژی و الکتروفیزیولوژی بالینی ایران سال 1401

“2021”

  1. Bayesian Structural Time Series of Multiple Sclerosis Projection in Tehran, Iran / ECTRIMS 2021
  2. Epidemiology of COVID-19 among MS Population Population-Based Registry Study in Iran / ECTRIMS 2021
  3. Famlial Multiple Sclerosis Risk in Iran A population-based registry study / ECTRIMS 2021
  4. Determining the Effect of Sun Exposure and Physical Activity on the Incidence of PPMS / ECTRIMS 2021
  5. Prevalence of MS in Tehran, Iran in 2020 and its forecast for the next 10 years / MENACTRIMS 2021
  6. Challenges of MS Patients for Receiving Health Care Services / MENACTRIMS 2021
  7. Epidemiology of COVID-19 in MS patients: A Population-Based Registry Study in Iran / MENACTRIMS 2021
  8. Water-pipe and cigarette smoking, drug abuse and alcohol consumption and the risk of primary progressive multiple sclerosis: A population-based case-control study / MENACTRIMS 2021

“2020”

  1. Epidemiology and MS Prevalence in Tehran Province, Iran / ECTRIMS 2020
  2. ادغام پایگاه های داده کووید 19 در سیستم ثبت ملی مولتیپل اسکلروزیس ایران / همایش ملی مجازی دستاوردهای پژوهشی کووید 19 کشور – سال 1399

“2018”

    1. Validity and Reliability of National Multiple Sclerosis Form for Registry Rystem in Iran / ECTRIMS 2018
    2. Principles for Planning National MS Registry System and Impact on Patient Care and Health Outcomes / MENACTRIMS 2018
    3. Multiple Sclerosis Minimum Data Set for National Registry System in Iran- Definition Validity and Reliability / MENACTRIMS 2018
    4. دومین کنگره ثبت بیماری‌ها و پیامدهای سلامت – سال 1397 :
      1. اصول برنامه‌ریزی سیستم ملی ثبت ام‌اس و تأثیر آن
      2. روایی و پایایی اقلام اطلاعاتی برنامه ثبت ام‌اس ایران

سخنرانی‌ها (ام اس):

  • معرفی سیستم ثبت ام اس ایران / کنگره ثبت بیماری‌ها و پیامدهای سلامت 1397
  • Iranian multiple sclerosis registry in adult / هجدهمین کنگره ام‌اس ایران 1400
  • Epidemiology of MS in Iran / نوزدهمین کنگره ام‌اس ایران 1401
  • Epidemiological view of national MS registry in Iran / بیستمین کنگره ام‌اس ایران 1402

پوسترها (ام اس):